Trial · NCT04322708
Results by group63
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 63
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Subjects Who Achieve a Peak Esophageal Intraepithelial Count of ≤6 Eosinophils/Hpf at Week 24 | 1 mg/kg of Lirentelimab (AK002) | 86 | Participants | ||
| Proportion of Subjects Who Achieve a Peak Esophageal Intraepithelial Count of ≤6 Eosinophils/Hpf at Week 24 | 3 mg/kg of Lirentelimab (AK002) | 80 | Participants | ||
| Proportion of Subjects Who Achieve a Peak Esophageal Intraepithelial Count of ≤6 Eosinophils/Hpf at Week 24 | Placebo | 10 | Participants | ||
| Change in Dysphagia Symptom Questionnaire (DSQ) Score From Baseline to Weeks 23-24. | 1 mg/kg of Lirentelimab (AK002) | -11.9 | Standard Error 1.8 | Score on a scale | |
| Change in Dysphagia Symptom Questionnaire (DSQ) Score From Baseline to Weeks 23-24. | 3 mg/kg of Lirentelimab (AK002) | -17.4 | Standard Error 1.8 | Score on a scale | |
| Change in Dysphagia Symptom Questionnaire (DSQ) Score From Baseline to Weeks 23-24. | Placebo | -14.6 | Standard Error 1.8 | Score on a scale | |
| Percent Change in Peak Esophageal Intraepithelial Eosinophil Count From Baseline to Week 24 | 1 mg/kg of Lirentelimab (AK002) | -98.9 | Standard Deviation 5.6 | Percentage of Change | |
| Percent Change in Peak Esophageal Intraepithelial Eosinophil Count From Baseline to Week 24 | 3 mg/kg of Lirentelimab (AK002) | -99.6 | Standard Deviation 1.0 | Percentage of Change | |
| Percent Change in Peak Esophageal Intraepithelial Eosinophil Count From Baseline to Week 24 | Placebo | -3.1 | Standard Deviation 76.0 | Percentage of Change | |
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of ≤1 Eosinophil/Hpf at Week 24 | 1 mg/kg of Lirentelimab (AK002) | 82 | Participants | ||
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of ≤1 Eosinophil/Hpf at Week 24 | 3 mg/kg of Lirentelimab (AK002) | 77 | Participants | ||
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of ≤1 Eosinophil/Hpf at Week 24 | Placebo | 4 | Participants | ||
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of <15 Eosinophils/Hpf at Week 24 | 1 mg/kg of Lirentelimab (AK002) | 86 | Participants | ||
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of <15 Eosinophils/Hpf at Week 24 | 3 mg/kg of Lirentelimab (AK002) | 80 | Participants | ||
| Subjects Achieving Peak Esophageal Intraepithelial Eosinophil Count of <15 Eosinophils/Hpf at Week 24 | Placebo | 14 | Participants | ||
| Number of Treatment Responders | 1 mg/kg of Lirentelimab (AK002) | 42 | Participants | ||
| Number of Treatment Responders | 3 mg/kg of Lirentelimab (AK002) | 53 | Participants | ||
| Number of Treatment Responders | Placebo | 8 | Participants | ||
| Subjects Who Achieve >50% Reduction in DSQ Score From Baseline to Weeks 23-24 | 1 mg/kg of Lirentelimab (AK002) | 40 | Participants | ||
| Subjects Who Achieve >50% Reduction in DSQ Score From Baseline to Weeks 23-24 | 3 mg/kg of Lirentelimab (AK002) | 48 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04322708/results